1716. Meet-the-Professor
Session: Meet-the-Professor Session: When to Switch Antiretroviral Therapies
Saturday, October 29, 2016: 7:20 AM
Room: 288-290
Roger Bedimo, MD, Medicine, VA N Texas Health Care Systems, University of Texas, Dallas, TX


R. Bedimo, Merck & Co.: Scientific Advisor , Research grant
Theratechnologies: Scientific Advisor , Research grant
Bristol Myers Squibb: Scientific Advisor , Research grant
Gilead: Scientific Advisor , Consulting fee

<< Previous Presentation | Next Presentation

Findings in the abstracts are embargoed until 12:01 a.m. CDT, Wednesday Oct. 26th with the exception of research findings presented at the IDWeek press conferences.